The Company provides healthcare services across secondary and tertiary care specialities, focusing on oncology, neurosciences, cardiac sciences, orthopaedics, renal sciences, liver and biliary sciences and minimal access metabolic and bariatric surgery (“MAMBS”) at the Network Healthcare Facilities.
Closing above 449 wil bring 500 , 522
Trading above 10 , 20 , 50 , 100 , 200 EMA
Company with good fundamentals except valuation.
Recommended to enter above 449
Closing above 449 wil bring 500 , 522
Trading above 10 , 20 , 50 , 100 , 200 EMA
Company with good fundamentals except valuation.
Recommended to enter above 449
Transaction en cours:
Reached 483